低剂量酸增强了在甲状腺切除的老鼠中因缺血再输液诱导的胃的愈合
Adeola Temitope Salami1, Chidinma Chukwukaeme2, Olawande Olagoke3
1Department of Physiology, College of Medicine, University of Ibadan. adeolathabitha@yahoo.com.
概括
低剂量酸通过改善氧化还原平衡和细胞功能,类似于甲状腺素治疗,在甲状腺功能低下的老鼠中增强了胃的愈合.
科学领域:
- 内分泌学和毒理学.
- 胃肠道学和伤口治疗
背景情况:
- 甲状腺激素极大地影响新陈代谢和伤口愈合,失衡会影响胃的恢复.
- 低剂量的异生菌,如酸,对甲状腺功能和胃愈合的作用仍未得到充分研究.
- 了解这些相互作用对于改变甲状腺状态的胃肠道健康管理至关重要.
研究的目的:
- 评估低剂量酸对低甲状腺小鼠胃愈合的影响.
- 研究酸在各种甲状腺状态下的作用背后的氧化还原和细胞机制.
- 为了比较酸与甲状腺素治疗在促进愈合方面的疗效.
主要方法:
- 雄性Wistar大鼠被分配到正常,性或甲状腺切除组,其中一些接受酸或甲状腺素.
- 胃的愈合被监测,同时测量体重,甲状腺素水平,胃粘素,氧化还原状态和肝/血液毒性标志物.
- 使用描述性统计和ANOVA (α=0.05) 分析了数据.
主要成果:
- 在甲状腺功能低下的老鼠中,酸的使用显著增强了胃的愈合,减少了和炎症.
- 在胃和肝组织中观察到低水平的甲 (脂质过氧化的标志物).
- 甲状腺素和酸治疗改善了氧化还原平衡,增加了catalase和sulfhydryl水平,并提高了Na+/K+-ATPase活性.
结论:
- 低剂量的酸有效地促进了在甲状腺功能低下状态下胃的愈合.
- 治疗效果与改善的氧化还原状态和细胞功能有关,与甲状腺素相当.
- 这项研究强调了酸在特定甲状腺条件下治疗胃的潜在治疗作用.
相关概念视频
01:26Peptic Ulcer Disease IV: Management
89
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
89
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
465
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
465
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
418
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
418
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
527
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
527